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The objective of the study was to assess antibiotic resistance and molecular epidemiology of 24 
Shigella isolates from a case-control study of diarrhea, conducted from 2007-2012 in children less 25 
than 5 years in Manhiça district, southern Mozambique. All isolates were tested for antimicrobial 26 
susceptibility using disc-diffusion method. PCR was used to detect different molecular 27 
mechanisms of antibiotic resistance. Serotyping was performed using specific antisera. Clonal 28 
relationship for S. flexneri and S. sonnei was assessed by Pulsed-Field Gel Electrophoresis (PFGE). 29 
Of the 67 analyzed Shigella isolates, 59 were diarrheal cases and 8 controls. S. flexneri (70.1%; 30 
47/67), was the most frequent species followed by S. sonnei (23.9%; 16/67). The most prevalent 31 
S. flexneri serotypes were 2a (38.3%; 18/47), 6 (19.2%; 9/47) and 1b (14.9%; 7/47). High rates of 32 
antimicrobial resistance were observed for trimethoprim/ sulfametoxazole (92.5%; 62/67), 33 
tetracycline (68.7%; 46/67), chloramphenicol (53.7%; 36/67) and ampicillin (50.7%; 34/67). 34 
Multidrug resistance was present in 55.2% (37/67) of the isolates and was associated with 8.1% 35 
(3/37) case fatality rate. PFGE revealed 22 clones (16 for S. flexneri and 6 for S. sonnei), among 36 
which, P1 (31.9%; 15/47), P9 (17%; 8/47) and P2 (10.6%; 5/47) were the most prevalent S. flexneri 37 
clones. In conclusion, S. flexneri was the most prevalent species with MDR isolates mainly 38 
belonging to three specific clones (P1, P9 and P2). The case fatality rate observed only for MDR 39 
isolates is a matter of concern indicating the need for appropriate treatment.  40 
 41 
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1. Introduction 46 
According to the World Health Organization (WHO), diarrheal diseases remain as one of the most 47 
common and major causes of infant mortality in children in developing countries. Despite 48 
advances in the understanding of the disease and management strategies, globally 0.75 million 49 
children die annually as a consequence of diarrhea [1] and 165 million cases of dysentery annually 50 
were estimated to occur due to Shigella [2]. However, more recent estimations place Shigella 51 
disease burden around 90 million episodes and 108,000 deaths per year [3] which is still high.  The 52 
wide spread of disease can be explained by the low infectious dose of the bacterium (10-100 cells), 53 
the direct person-to-person transmission, contaminated food and water transmission, and its low 54 
susceptibility to stomach acids [4]. In terms of clinical impact, Shigella is the enterobacteria 55 
showing the most serious outcome with fever, abdominal cramps and blood and mucus in the 56 
stools. The contribution of vectors, such as houseflies, has also been assessed and may contribute 57 
to the spread of the disease [5]. 58 
The role of Shigella spp. as causing childhood diarrhea in developing areas is probably the most 59 
recognized context in the epidemiology of shigellosis.  A recently published 3-year, multicenter, 60 
prospective, matched case-control study of moderate-to-severe diarrhea (the Global Enteric 61 
Multicenter Study - GEMS) [6], evaluated the cause and impact of diarrheal diseases in over 62 
22,000 children under 5 years from seven different sites of Asia and Africa including Mozambique. 63 
The study confirmed Shigella spp. among the top five important pathogens associated with 64 
childhood diarrhea [6]. Furthermore, several other studies have reported Shigella associated 65 
diarrhea in children living in areas with poor resources [7–9]. In developed countries, Shigella 66 
have been isolated especially during outbreaks of gastroenteritis following ingestion of 67 
contaminated food or water [10,11]. 68 
Four species of Shigella with 50 serotypes are currently recognized namely, S. dysenteriae (15 69 
serotypes), S. flexneri (15 serotypes), S. boydii (19 serotypes) and S. sonnei (1 serotype) [12], 70 
among them, S. flexneri and S. sonnei are responsible for endemic forms of disease whereas S. 71 
dysenteriae 1 accounts for devastating epidemics [13]. Although the epidemiology of Shigella may 72 
vary from region to region, S. sonnei is being predominant in developed countries while S. flexneri 73 
 
 
in those less developed [14]. However, a change in trend has been reported from developing 74 
countries, where S. flexneri serotypes have been replaced by S. sonnei in areas undergoing 75 
economic development and improvements in hygiene [15,16] which supports the importance of 76 
continuous surveillance to track disease epidemiology changes.  77 
In addition to the diversity of Shigella, there is an increasing rate of antibiotic resistance for the 78 
most common used therapy (ampicillin, tetracycline, chloramphenicol, sulfonamides, 79 
sulphamethoxazole-trimethoprim and nalidixic acid) putting a serious threat for patient 80 
management. This scenario leads to the use of more expensive new-generation antibiotics such as 81 
fluoroquinolones though resistance has also been reported [17]. The rapid emergence of multidrug-82 
resistant (MDR) strains is largely due to their ability to acquire and disseminate exogenous genes 83 
associated with mobile genetic elements such as, transposons, integrons, plasmids, and other 84 
genomic islands [18]. Thus, the ability to recognize and characterize multidrug resistant clones, 85 
will favor the development of preventive measures for infection control. Although  Shigella 86 
infections has been previously reported in Mozambique [19], including data from the Global 87 
Enteric Multicenter Study (GEMS) [12], the molecular epidemiology and the impact of multidrug 88 
resistance in patient outcome of these infections remain unknown. Therefore, we hereby present 89 
analysis of the trends of antibiotic resistance and clonal relatedness of Shigella isolates from 90 
children aged less than 5 years in Manhiça District enrolled as part of the GEMS study from 91 
December, 2007 to November, 2012. This information will allow us to evaluate if there is a 92 
particular clone showing antibacterial resistance circulating in the area of study. 93 
 94 
2. Material and methods 95 
2.1.Study area  96 
The study was conducted by the Manhiça Health Research Centre (Centro de Investigação em 97 
Saúde de Manhiça – CISM) in Manhiça district, a rural area of Maputo province in southern 98 
Mozambique. Since 1996, CISM has been running a Health Demographic Surveillance System 99 
(HDSS) for vital events and migrations in the population living within the study area covering 100 
approximately 95,000 inhabitants. In 2014, the study area was expanded to the whole District 101 
currently covering 183,000 inhabitants. Each person living within the DSS study area is issued a 102 
unique Permanent Identification Number that describes the geographic location, household 103 
 
 
number and personal number within the household. A full description of the geographic and socio-104 
demographic characteristics of the study community has been detailed elsewhere [20]. 105 
2.2.Bacterial isolates and study population 106 
All isolates analyzed were collected from a case-control study of diarrhea conducted by CISM at 107 
Manhiça district from December 2007 to November 2012 with the main objective to estimate the 108 
burden and etiology of moderate-to-severe diarrhea (MSD) in children less than 5 years of age to 109 
guide future interventions. Cases of less severe diarrhea were also included from 3rd November 110 
2011 to 2nd November 2012. Age in months was stratified in three strata (0-11, 12-23 and 24-59). 111 
Clinical and epidemiological data were collected over the study period. Cases of diarrhea were all 112 
children under 5 living within the HDSS area presenting to Manhiça district hospital with 113 
symptoms of diarrhea, defined as three or more loose stools in the last 24 hours. Study clinicians 114 
assessed each child with diarrhea for eligibility. To be included, the episode had to be new (onset 115 
after ≥7 diarrhea-free days), acute (onset within the previous 7 days), and fulfill at least one of the 116 
following criteria for moderate-to-severe diarrhea: sunken eyes (confirmed by parent or caretaker 117 
as more than normal); loss of skin turgor (abdominal skin pinch with slow [≤2 s] or very slow [≥2 118 
s] recoil); intravenous hydration administered or prescribed; dysentery (visible blood in loose 119 
stools); or admission to hospital with diarrhea or dysentery [6]. For each child with diarrhea, one 120 
to three healthy control children (no story of diarrhea in the previous 7 days, matched by age, sex 121 
and neighborhood) were randomly selected using the HDSS database and enrolled within 14 days 122 
of presentation of the corresponding index case. Case fecal samples were collected within 12 hours 123 
of registration of the diarrheal episode, and control samples within 14 days after case enrolment. 124 
Once collected, samples were kept in a cool box until processed. Children were not enrolled if 125 
unable to produce fecal samples within the established first 12 hours or prior to the initiation of 126 
antibiotics. Each fecal specimen comprised a whole stool specimen (in screw top fecal specimen 127 
cups carried in Styrofoam boxes with cold packs), a fecal swab in Modified Cary Blair medium in 128 
a plastic screw top test tube, and a fecal swab in buffered glycerol saline in a screw top test tube 129 
[21]. Additionally, if antibiotics were to be given to patients before stool was produced, we 130 
obtained two rectal swabs for bacterial culture pending passage of the whole stool for the 131 
remaining assays. Fecal specimens were platted on specific culture media for detection of bacterial 132 
pathogens according to standard methods. Shigella species were identified by colonies morphology 133 
 
 
upon culturing in MacConkey and XLD following by slide agglutination with specific antisera 134 
(Denka Seiken Co., Ltd., Tokyo, Japan). Quality control was performed at the Centers for Vaccine 135 
Development (CVD), University of Maryland, USA. At least one enteropathogen was identified 136 
in 79% (2968/3757) and two or more microbial agents in 41% (1540/3757) of the analyzed stool 137 
samples. Overall, Shigella was isolated in 2.1% (79/3757), of which 67 were characterized in the 138 
present study. Forty-nine (73.1%) were recovered from moderate-severe-diarrhea (MSD) and 18 139 
(26.9%) from less-severe-diarrhea (LSD). The proportion of cases of diarrhea among the analyzed 140 
isolates was 88.1% (59/67) and 11.9% (8/67) for controls. In addition, the isolates were mostly 141 
from older children aged 24-59 months (47.8%; 32/67) followed by 12-23 months (41.8%; 28/67) 142 




2.3.Antimicrobial susceptibility and resistance mechanisms 147 
Antimicrobial susceptibility was assessed by disk diffusion method according to the Clinical and 148 
Laboratory Standard Institute (CLSI) [22] for chloramphenicol (30 µg), nalidixic acid (30 µg), 149 
ciprofloxacin (5 µg), ampicillin (10 µg), amoxicillin plus clavulanic acid (30 µg), gentamicin (10 150 
µg), tetracycline (10 µg), ceftriaxone (30 µg), cefotaxime (30 µg), tobramycin (10 µg), 151 
trimethoprim-sulfametoxazole (25 µg). Multidrug resistance was defined as the presence of 152 
resistance in at least three unrelated class of antibiotics. Molecular determinants of resistance were 153 
screened by PCR using specific protocols for β-lactams (TEM [23], SHV, OXA-1 [24], CTX-M 154 
[25]), tetracycline (tetA, tetB, tetD), chloramphenicol (cmlA, floR) and 155 
trimethoprim/sulfametoxazole (dfrIa, dfr8, dfr12) [23].  For DNA extraction, the isolates were 156 
recovered from -70°C freezer, streaked on MacConkey agar plates and incubated for 18-24 hours 157 
in a 37oC incubator. A loop full of bacterial colonies was suspended into 500µl of distilled water 158 
and boiled for 10 minutes in a heat block and then centrifuged at 10,000 xg for 10 minutes. The 159 
supernatant was used as DNA template for PCR. DNA amplification was performed into 0.2ml 160 
Eppendorf tubes in 25µl reaction volume. Master Mix was prepared by adding 12.5 µl of PCR 161 
master mix 2X (Qiagen Multiplex PCR kit), 10 µM of each primer (0.5 µl), 2.5µl of Q-solution 162 
1X, 2 µl of PCR water (nuclease free) and 2µl of DNA template. The amplified product was 163 
visualized in 2% agarose gel after staining with ethidium bromide. Sequencing of PCR products 164 
 
 
was performed at Macrogen (https://dna.macrogen.com/eng/). DNA sequences were assigned 165 
using the BLAST nucleotide sequence search tool. 166 
 167 
2.4.Clonal relatedness studies 168 
The relationship of the isolates was evaluated by Pulsed-Field Gel Electrophoresis (PFGE). PFGE 169 
analysis was based on the PulseNet standardized PFGE protocol [26]. Shigella plugs were prepared 170 
with 1% agarose (Lonza Incert agarose, cat. 50123, Lonza Rockland, ME, USA) and digested with 171 
XbaI (New England Biolabs) restriction enzyme according to the manufacturer’s instructions. 172 
Plugs of Salmonella enterica H9812 (Biorad) was used as positive control for all PFGE assays.  173 
Electrophoresis in agarose gel Biorad 1% (Certified Megabase Agarose, cat. 161-3109, Biorad 174 
laboratories, Inc, Hercules, USA) was performed with the CHEF-DR III System (Bio-Rad 175 
Laboratories, Hercules, CA, USA) in total volume of 2 L 0.5X TBE buffer previously cooled to 176 
14°C in the electrophoresis chamber. The program was at 14°C, 200V (6 V/cm2), 20 h, with switch 177 
times of 5–35 s. Gels were stained with Syber safe and visualized under UV light. Restriction 178 
patterns were analyzed through the infoQuestTM FP software v.4.5 (Biorad laboratories, Inc, 179 
Hercules, USA) with 1% Dice coefficient tolerance. Isolates with at least 85% of similarity were 180 
considered as the same profile and clones were defined as PFGE clusters containing more than one 181 
isolate.  182 
 183 
2.5.Data analysis  184 
Laboratory data were entered to Microsoft excel file and combined to clinical information. 185 
Statistical analyses were performed using STATA software, version 14.1. Proportions were 186 
compared using the chi-square test or Fisher’s exact test, as appropriate. 187 
 188 
3. Results 189 
3.1.Species prevalence and antibiotic resistance 190 
Among the 67 analyzed isolates, 3 different Shigella species were found, being S. flexneri (70.1%; 191 
47/67), the most dominant followed by S. sonnei (23.9%; 16/67), two S. boydii (3%) and two (3%) 192 
isolates which species could not be identified. The most prevalent S. flexneri serotypes were 2a 193 
(38.3%; 18/47), 6 (19.1%; 9/47) and 1b (14.9%; 7/47). Antimicrobial resistance was observed for 194 
 
 
both cases and controls with high rates for trimethoprim/ sulfametoxazole (92.5%; 62/67), 195 
tetracycline (68.7%; 46/67), chloramphenicol (53.7%; 36/67) and ampicillin (50.7%; 34/67). S. 196 
flexneri was responsible for 70.1% (47/67) of the overall antibiotic resistance compared to 29.9% 197 
(20/67) for other species altogether. Thirty-seven (55.2%) were multidrug resistant found in both 198 
cases (91.8%; 34/37) and controls (8.1%; 3/37). Additionally, the majority of MDR isolates were 199 
from S. flexneri (47.7.7%; 32/67) compared to 7.4% (5/67) for other species (Table 1).  The isolates 200 
remain susceptible to third generation cephalosporin (ceftriaxone and cefotaxime), quinolones 201 
(nalidixic acid and ciprofloxacin) and aminoglycosides (gentamicin and tobramycin) (data not 202 
shown). Overall, 82.1% (55/67) of the isolates possessed at least one gene conferring antibiotic-203 
resistance, being the mostly found the dfrIa gene (59.7%; 40/67) followed by OXA-1 (47.8%; 204 
32/67), dfr8 (41.8%; 28/67) and tetB (40.3%; 27/67) (Table 2). No TEM, SHV, cmlA and dfr12 205 
genes were detected in the analyzed isolates. 206 
3.2. Epidemiological study 207 
An overview of PFGE fingerprinting and strain information for individual isolates is illustrated in 208 
the Table 3. Fig. 1 shows the dendogram with PFGE image of S. flexneri and S. sonnei isolates. 209 
Twenty-two clusters were found, 16 for S. flexneri and 6 for S. sonnei. All S. flexneri isolates 210 
except 9, considered as singletons, belonged to 7 different clones. Regarding to S. sonnei, 4 clones 211 
were identified and 2 isolates were singletons. The predominant S. flexneri clones were P1 (31.9; 212 
15/47), P9 (17%; 8/47) and P2 (10.6%; 5/47). In the case of S. sonnei isolates, they were mostly 213 
represented by P1 and P5 with 25% of the isolates for each clone (4/16). 214 
In terms of evolution of the clones across the years, S. flexneri P1 clone was found through the 215 
whole study period (except 2007), P9 from 2009-2012 and P2 was only detected in 2011 and 2012. 216 
In contrast to S. flexneri, the distribution of S. sonnei clones was irregular however the main clones 217 
(P1 and P5) were mostly detected in 2012. Clonality among MDR isolates was observed as all 218 
MDR S. flexneri isolates were clustered in different clones (94.1%; 32/34) except two isolates 219 
(strain 310058 and 303291). Similar finding was observed for S. sonnei in which all MDR isolates 220 
were clonal. Furthermore, all died children (5%; 3/60) were MDR carries. Interestingly, the most 221 
commonly found MDR pattern was the combination of antibiotics including CHL-TET-AMC-222 
AMP-SXT (72.9%; 27/37). Then, the same combination excluding amoxicillin-clavulanic acid 223 
 
 
(CHL-TET-AMP-SXT) was found in 10.8%; (4/37) of the isolates, and, in the same proportion, 224 
the combination of CHL-TET-SXT followed by CHL-TET-AMC-AMP (8.1%; 3/37). 225 
 226 
4. Discussion 227 
In the present study, we characterized a collection of Shigella spp recovered from a case-control 228 
study of diarrhea in children less than five years in Manhiça District, Southern Mozambique from 229 
2007 to 2012. Our findings demonstrate that the main burden of Shigella infections is from children 230 
aged 1-5 years, with the dominance of S. flexneri compared to other species. This  observation 231 
supports the idea that Shigella species are geographically stratified based on the level of economic 232 
development in a given country [16] being S. flexneri the primary infectious species in developing 233 
countries whereas S. sonnei rates increase with economic development [16,27,28]. Currently, S. 234 
flexneri is predominant through Southeast Asia and Africa [12,29,30]. Additionally, the high 235 
prevalence of S. flexneri serotype 2a correlates with its clinical importance as the main target 236 
Shigella vaccine [31]. It has been postulated that a combination of four components which includes 237 
S. flexneri serotypes 2a, 3a, 6 and S. sonnei could provide an overall coverage of 88% through 238 
direct protection and cross protection among S. flexneri serotypes based on shared type and group-239 
O antigen determinants [12]. This observation is in concordance with our findings where these 240 
serotypes together with S. flexneri 1b were the most prevalent.  241 
Adding to the diversity of Shigella, we also report a high level of antimicrobial resistance in the 242 
analyzed isolates to commonly used antibiotics (ampicillin, tetracycline, chloramphenicol and 243 
trimethoprim/sulfametoxazole), being S. flexneri much more resistant compared to all other 244 
species. This finding correlate with the global spreading of antibiotic resistance associated with 245 
the extensive use of these antibiotics in clinical practices [15]. In Mozambique, for example, 246 
trimethoprim/sulfametoxazole is still used as prophylaxis against HIV exposure. In addition, the 247 
high rates of antibiotic resistance among S. flexneri isolates observed in the present study compared 248 
to other species, have been also reported [19] and might suggest possible genetic differences 249 
among species. An important result shown in this study is the presence of MDR in isolates from 250 
the control group (community children with no symptoms of diarrhea); this is worrisome since 251 
they may act as reservoir for infection transmission. Most of them were S. flexneri (2 out of 3 252 
 
 
MDR control isolates identified) which emphasize the high burden of S. flexneri in this rural 253 
Mozambique. In addition the observed case fatality rate of MDR isolates represents a serious 254 
public health concern and argues for rapid diagnostic for appropriate treatment.   255 
Our finding also supports the importance of genes encoding resistance determinants in the 256 
spreading of MDR as showed by the occurrence of resistance mechanisms such as of dfrIa, OXA-257 
1 and tetB genes. Indeed, trimethoprim/sulfamethoxazole resistance is most commonly acquired 258 
through a plasmid-encoded variant of the dihydrofolate reductase while ampicillin resistance is 259 
mediated by beta-lactamases encoding genes such as TEM-1 and OXA-1 [28]. Moreover, the tet-260 
like genes are responsible for most of tetracycline resistance [19]. However, in the present study, 261 
some resistant mechanisms could not be elucidated based on the screened genes, suggesting that 262 
other mechanisms seem to be contributing to the resistance phenotype, which is consistent with 263 
other reports [19,24]. Thus, additional studies are needed in order to go further in this 264 
determination. In contrast to other studies [17,32], our isolates remain susceptible to third 265 
generation cephalosporin (ceftriaxone and cefotaxime), quinolones (nalidixic acid and 266 
ciprofloxacin) and aminoglycosides (gentamicin and tobramycin) probably due to their infrequent 267 
use as alternative in this geographic location.  268 
Although the high diversity, 60% of the S. flexneri isolates were represented by three dominant 269 
PFGE clusters composed mainly by the most frequent serotypes (1b, 2a and 6). The absence of 270 
dominant clones in S. sonnei can be explained in part due to the limited number of the analyzed 271 
isolates compared to S. flexneri. A good concordance between serotyping and PFGE genotyping 272 
was observed for S. flexneri 1b and 2b. All serotypes 1b belonged to the same PFGE profile, 273 
additionally most of 2a were grouped in a single cluster indicating minor genetic differences. 274 
Serotype 6 in contrast, showed more heterogeneity, with scattered isolates in different PFGE 275 
patterns. Similarly, isolates with the same antibiotic resistance profile were found in different 276 
PFGE and vice-versa; however, MDR isolates were more frequently found in clusters suggesting 277 
a possible clonal spreading. Indeed, PFGE profiles do not always accord with classic typing 278 
methods such as serotyping and antibiotic resistance, and PFGE is often usually a more 279 
discriminatory method. This was illustrated here where isolates of identical serotype and/or 280 
resistance pattern showed heterogeneity of DNA patterns by PFGE, which is similar to previous 281 
studies [34,35].  282 
 
 
In summary, this is the first report of molecular epidemiology of Shigella associated-diarrhea in 283 
Mozambican children. Our findings suggest the presence of high diversity of Shigella spp causing 284 
diarrhea in Mozambican children with multidrug resistant isolates belonging to a limited number 285 
of clones. MDR isolates are likely to be more lethal indicating the need for appropriate treatment. 286 
The presence of MDR carriers in the community is an alert for the importance of community-based 287 
interventions for infection prevention/control. S. flexneri 1b was importantly found in our 288 
collection although not included as targeted vaccine serotype suggesting continuous disease 289 
surveillance to track changes over time.  290 
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